Log in
NYSE:MDT

Medtronic Stock Forecast, Price & News

$103.63
+0.47 (+0.46 %)
(As of 09/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$103.46
Now: $103.63
$105.39
50-Day Range
$98.73
MA: $104.07
$108.78
52-Week Range
$72.13
Now: $103.63
$122.15
Volume3.33 million shs
Average Volume5.94 million shs
Market Capitalization$139.30 billion
P/E Ratio31.69
Dividend Yield2.25%
Beta0.68
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation product; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; hardware instruments and mesh fixation device; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, colorectal surgeons, urogynecologists, interventional radiologists, and ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More
Medtronic logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 3.3Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.62 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP58505510
Phone353-1438-1700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$28.91 billion
Cash Flow$6.41 per share
Book Value$37.53 per share

Profitability

Net Income$4.79 billion

Miscellaneous

Employees90,000
Outstanding Shares1,344,215,000
Market Cap$139.30 billion
Next Earnings Date11/17/2020 (Estimated)
OptionableOptionable
$103.63
+0.47 (+0.46 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medtronic (NYSE:MDT) Frequently Asked Questions

How has Medtronic's stock been impacted by COVID-19?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MDT shares have increased by 12.1% and is now trading at $103.63.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Medtronic?

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 1 sell rating, 4 hold ratings, 20 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Medtronic
.

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, November 17th 2020.
View our earnings forecast for Medtronic
.

How were Medtronic's earnings last quarter?

Medtronic PLC (NYSE:MDT) posted its quarterly earnings data on Tuesday, August, 25th. The medical technology company reported $0.62 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.21 by $0.41. The medical technology company earned $6.51 billion during the quarter, compared to the consensus estimate of $5.48 billion. Medtronic had a return on equity of 10.47% and a net margin of 15.80%. The company's quarterly revenue was down 13.2% compared to the same quarter last year. During the same period in the prior year, the company earned $1.26 EPS.
View Medtronic's earnings history
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Tuesday, August 25th. Shareholders of record on Friday, September 25th will be given a dividend of $0.58 per share on Friday, October 16th. This represents a $2.32 annualized dividend and a yield of 2.24%. The ex-dividend date of this dividend is Thursday, September 24th.
View Medtronic's dividend history
.

What price target have analysts set for MDT?

26 brokerages have issued 12-month price targets for Medtronic's shares. Their forecasts range from $92.00 to $135.00. On average, they anticipate Medtronic's share price to reach $116.93 in the next year. This suggests a possible upside of 12.8% from the stock's current price.
View analysts' price targets for Medtronic
.

Are investors shorting Medtronic?

Medtronic saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 6,300,000 shares, a decline of 13.6% from the August 31st total of 7,290,000 shares. Based on an average trading volume of 4,820,000 shares, the short-interest ratio is presently 1.3 days.
View Medtronic's Short Interest
.

Who are some of Medtronic's key competitors?

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), Walt Disney (DIS), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Verizon Communications (VZ).

Who are Medtronic's key executives?

Medtronic's management team includes the following people:
  • Mr. Omar S. Ishrak, Chairman & CEO (Age 63)
  • Ms. Karen L. Parkhill, Exec. VP, CFO & Principal Accounting Officer (Age 54)
  • Mr. Bradley E. Lerman, Sr. VP, Gen. Counsel & Company Sec. (Age 61)
  • Mr. Michael J. Coyle, Exec. VP and Group Pres of Cardiac & Vascular Group (Age 57)
  • Mr. Robert J. W. ten Hoedt, Exec. VP and Group Pres, Europe, Middle East & Africa (Age 58)

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $103.63.

How big of a company is Medtronic?

Medtronic has a market capitalization of $139.30 billion and generates $28.91 billion in revenue each year. The medical technology company earns $4.79 billion in net income (profit) each year or $4.59 on an earnings per share basis. Medtronic employs 90,000 workers across the globe.

What is Medtronic's official website?

The official website for Medtronic is www.medtronic.com.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.